Equitable Holdings’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-2,168
Closed -$350K – 1553
2025
Q2
$350K Sell
2,168
-43
-2% -$6.85K ﹤0.01% 1137
2025
Q1
$376K Sell
2,211
-7
-0.3% -$1.22K ﹤0.01% 1017
2024
Q4
$369K Sell
2,218
-35
-2% -$5.98K ﹤0.01% 968
2024
Q3
$387K Sell
2,253
-40
-2% -$6.62K ﹤0.01% 945
2024
Q2
$353K Sell
2,293
-185
-7% -$27.8K ﹤0.01% 945
2024
Q1
$381K Sell
2,478
-323
-12% -$49.3K ﹤0.01% 898
2023
Q4
$443K Sell
2,801
-750
-21% -$108K 0.01% 809
2023
Q3
$520K Sell
3,551
-231
-6% -$35.2K 0.01% 707
2023
Q2
$579K Buy
3,782
+273
+8% +$42.6K 0.01% 659
2023
Q1
$544K Sell
3,509
-1,136
-24% -$178K 0.01% 629
2022
Q4
$716K Buy
4,645
+423
+10% +$62.4K 0.01% 522
2022
Q3
$557K Sell
4,222
-40
-0.9% -$5.61K 0.01% 539
2022
Q2
$578K Buy
4,262
+105
+3% +$14.5K 0.01% 529
2022
Q1
$620K Buy
4,157
+1,295
+45% +$192K 0.01% 526
2021
Q4
$464K Buy
2,862
+975
+52% +$158K 0.01% 583
2021
Q3
$313K Buy
1,887
+507
+37% +$86.6K 0.01% 661
2021
Q2
$238K Hold
1,380
– – ﹤0.01% 732
2021
Q1
$221K Buy
1,380
+20
+1% +$3.42K ﹤0.01% 699
2020
Q4
$228K Sell
1,360
-4
-0.3% -$649 0.01% 623
2020
Q3
$215K Sell
1,364
-16
-1% -$2.62K 0.01% 579
2020
Q2
$232K Buy
+1,380
New +$217K 0.01% 559

Other funds holding FBT

Equitable Holdings's FBT Position: Q3 2025 in Review

Equitable Holdings sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2025, closing a stake of 2,168 shares — an estimated $350K sold.

Equitable Holdings first reported a position in FBT in Q2 2020 and held it in 21 quarters. The position peaked at $716K in Q4 2022. 253 funds tracked by Wall St. Rank hold FBT as of Q3 2025.

  • Equitable Holdings reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2025 after selling out during the quarter.
  • Equitable Holdings sold 2,168 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2025, an estimated $350K.
  • Equitable Holdings first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and held it in 21 quarters.
  • Equitable Holdings's First Trust NYSE Arca Biotechnology Index Fund position peaked at $716K in Q4 2022.
  • 253 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2025.

Based on Equitable Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.